More tools:Markets·Screener·Research·Chat

NeoGenomics, Inc. (NEO) Financial Statements

NeoGenomics, Inc.
SIC 8734 · SERVICES-TESTING LABORATORIES
FIGI BBG001S9DSY4
XNAS · usd
17.79▲ 0.23 (1.31%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close17.56
Day's Range16.95 – 17.84
52-Week Range7.06 – 19.76
Volume1.1M
Avg Volume2.2M
Share Statistics
Shares Outstanding
Employees2,500
ExchangeXNAS
Listed1996-01-25
Share count as of July 24, 2026
Loading Income Statement…
Key questions about NeoGenomics, Inc. (NEO)
What is NeoGenomics, Inc.'s Market Cap?
NeoGenomics, Inc.'s Market Cap is $2.3B, based on as-reported figures from SEC (XBRL) filings.
What is NeoGenomics, Inc.'s Enterprise Value?
NeoGenomics, Inc.'s Enterprise Value is $2.5B, based on as-reported figures from SEC (XBRL) filings.
What is NeoGenomics, Inc.'s Price / Sales?
NeoGenomics, Inc.'s Price / Sales is 3.0×, based on as-reported figures from SEC (XBRL) filings.
What is NeoGenomics, Inc.'s EV / Revenue?
NeoGenomics, Inc.'s EV / Revenue is 3.3×, based on as-reported figures from SEC (XBRL) filings.
What is NeoGenomics, Inc.'s EV / EBITDA?
NeoGenomics, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is NeoGenomics, Inc.'s Revenue (TTM)?
NeoGenomics, Inc.'s Revenue (TTM) is $766.3M, based on as-reported figures from SEC (XBRL) filings.
What is NeoGenomics, Inc.'s Net Income (TTM)?
NeoGenomics, Inc.'s Net Income (TTM) is -$51.9M, based on as-reported figures from SEC (XBRL) filings.
What is NeoGenomics, Inc.'s EBITDA?
NeoGenomics, Inc.'s EBITDA is -$3.0M, based on as-reported figures from SEC (XBRL) filings.
What is NeoGenomics, Inc.'s Diluted EPS (TTM)?
NeoGenomics, Inc.'s Diluted EPS (TTM) is -0.40, based on as-reported figures from SEC (XBRL) filings.
What is NeoGenomics, Inc.'s EBITDA Margin?
NeoGenomics, Inc.'s EBITDA Margin is -0.4%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
NET REVENUE
YoY growth+17.2%+11.2%
COST OF REVENUE
GROSS PROFIT
% of revenue45.6%43.3%
Operating expenses:
General and administrative
Research and development
Sales and marketing
Impairment charges (Note 5)—
Total operating expenses
% of revenue50.4%53.1%
LOSS FROM OPERATIONS
% of revenue-4.8%-9.8%
Interest income
Interest expense
Other (expense) income, net
Gain on extinguishment of debt (Note 6)—
Income (loss) before taxes
Income tax benefit
Net income (loss)
% of revenue1.1%-9.2%